MedPanel and Relay Technology Management Announce a Research and Consulting Collaboration
Relay Technology Management Inc. and MedPanel, LLC are pleased to announce they have entered into a working partnership to offer a differentiated set of consultative services to biopharma business executives. Under this collaboration, MedPanel’s industry-leading primary research platform, Insights, which provides insight from clinicians and other healthcare decision makers, and Relay’s Innovation Engine-powered solutions will …
Relay Technology Management Publishes Macrocyclic Peptide Interactive Dashboard in Nature SciBx Collection
Relay Technology Management Inc. is pleased to announce that its real-time, interactive macrocyclic peptide dashboard has been featured in a SciBX; Science-Business eXchange collection. The collection on Macrocycles and Constrained Peptides features prominent scientific papers, review articles, and analysis pieces, with a focus on the potential these molecules have to open up new space for …
Interactive Dashboard: Immunokinase Targets
You’ve explored our un-partnered Alzheimer’s assets dashboard and our trends in novel epigenetics dashboard. We’d now like to offer you a look into our immunokinase targets dashboard, in which we profile select immunokinases, focusing on novel metrics in three interactive dashboards. We examined the trends between BTK (Bruton’s Tyrosine Kinase), IRAK4 (interleukin-1 receptor-associated kinase 4), JAK1 (Janus …
Can biotech hubs like Boston be replicated?
There are undeniable benefits for companies that are part of a biotech hub within a larger city. Companies that previously took refuge in the spacious executive parks of suburbs across the United States are now giving up their highway-accessible havens for offices along busy public transit lines, eager to become a part of the action …
The Importance of Business Development Planning
Relay’s Managing Director and Co-Founder, Dave Greenwald, is speaking today on Nutter McClennan and Fish LLP’s TCN Life Sciences Fast Track panel focusing on operational challenges for start-ups, alongside several other experts on business foundations and operations. While the panel is sure to cover business challenges of companies at all stages, here at Relay Technology …
Nature Publishing Group Publishes Open-Access Article Containing Relay’s Next Generation Epigenetics Drug Target Dashboard
Nature Publishing Group Releases Open-Access Article Containing Next Generation Epigenetics Drug Target Dashboard Powered by Relay Technology Management First of six open-access articles featuring dashboards from Nature’s strategic partner published today in Nature Reviews Drug Delivery CAMBRIDGE, MA – Relay Technology Management Inc. is pleased to announce that a series of six articles featuring Relay …
Curating a Conversation between BD and R&D
Today marks the publication of the first of six articles in Nature Reviews Drug Discovery that feature interactive dashboards powered by the Relay Innovation Engine. The article features our epigenetics targets interactive dashboard, Relay Technology Management Inc. is pleased to announce that a series of six articles featuring Relay Innovation Engine-powered interactive dashboards will be published open-access …
JPMorgan 2013: Trends in Regulatory, Reimbursement, and Early-Stage Deals
Relay’s managing directors, Brigham Hyde and Dave Greenwald, recently returned from the JP Morgan Healthcare Conference 2013 (JPM). The conference was abuzz with a fresh sense of optimism and excitement that hasn’t been seen in the biopharma industry in recent memory. From management teams to seasoned executives and venture capitalists, the change in attitude and …
Announcing Version 1.2 of BD Live!: Now Featuring Pipeline-by-Pathway Target Searching
Relay Technology Management Inc. is pleased to announce the release of the pipeline-to-pathway target searching module as part of version 1.2 of Business Development Live!, Relay’s flagship real-time comparative asset analysis and trend analytics software-as-a-service for the life sciences industry. From protein sequences to inhibitor connections, BD Live! enables life sciences professionals to access the …
Early-Stage Biopharma Investment Strategies
When it comes to mergers, acquisitions, and licensing strategy in biopharma, every company has a unique, individual strategy based on their respective resources, assets, and strategic plan. It’s important for each company to repeatedly internally assess their potential strategies, and make decisions from there about how to proceed or what changes to make. These analyses …
